Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.80 |
| ▸ | MEN1 | O00255 | 4/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.80 |
| ▸ | MAPT | P10636 | 4/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.80 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.80 |
| ▸ | RECQL | P46063 | 2/20 | 0.80 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.80 |
| ▸ | POLB | P06746 | 2/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.80 |
| ▸ | GAA | P10253 | 2/20 | 0.80 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.80 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.74 |
| ▸ | APP | P05067 | 1/20 | 0.74 |
| ▸ | XDH | P47989 | 1/20 | 0.66 |
| ▸ | CBS | P35520 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydrokaempferol SCHEMBL3437565 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL2036629 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL13354175 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL39319 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL31026899 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL3438673 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL29367287 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL31547241 | 0.93 | MAPT (0.70) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Pinobaksin SCHEMBL1045054 | 0.91 | MAPT (0.75) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Pinobaksin SCHEMBL14461145 | 0.91 | MAPT (0.75) | CYP3A4MEN1KMT2AMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| EP-4627099-A2 | PROCESS FOR MAKING FLAVANONE DERIVATIVES | Firmenich SA (CH) | 2025-10-08 | — | — | EP | disclosed |
| CN-118307618-A | Flavone glycoside compounds in golden camellia, preparation method thereof and application thereof in preparation of alpha-glycosidase inhibitor | 广西大学 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024115469-A2 | PROCESS FOR MAKING FLAVANONE DERIVATIVES | FIRMENICH SA (CH) | 2024-06-06 | — | — | WO | disclosed |
| CN-114146083-B | Sophora japonica extract and active ingredient and application thereof in preparation of products for treating glycolipid metabolism comprehensive disorder | 天津科技大学 | 2024-05-24 | — | — | CN | disclosed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| CN-114146083-A | Sophora flower extract and active component and application thereof in preparation of product for treating glycolipid metabolic syndrome | 天津科技大学 | 2022-03-08 | — | — | CN | disclosed |